Snatched Ventures — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Amprion develops and offers SAAmplify-αSYN, a validated diagnostic test that detects misfolded pathological α-synuclein in cerebrospinal fluid to support the diagnosis of neurodegenerative disorders such as Parkinson's, Lewy body dementia, and Alzheimer's.
BiotechDigital HealthMedical DevicesSan Francisco, US
Russell Lebovitz(Director, CEO & Stockholder)inClaudio Soto(Co-founder)Russ Lebovitz(Co-founder)Peter Clinton(Director)
BoardMarc Chan(Director & Stockholder)Rahul Bhansali(Director)
Anaplan offers a scenario planning and analysis platform that combines deterministic calculations, probabilistic AI, connected data, workflows, and role-based agents to support enterprise decision-making.
AI & Machine LearningEnterprise SoftwareSaaSNew York, US
JAMES THEUERKAUF(Executive Officer, Director)FERDINAND STOCKMANN(Director)
Co-investors2.12 AngelsAccelFlybridge Capital PartnersGradient VenturesOvereasy VenturesRackhouse Venture Management Lp+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.